Prius: 301257 Prius Research Activity Information 20240902
Prius: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Prius: Announcement of Supervisory Board Resolutions
Prius: Announcement of Board Resolutions
Prius: Huatai United Securities Co., Ltd.\'s 2024 on-site inspection report on Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.
Prius: Huatai United Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.
SMO Clinplus: Announcement regarding the proposal for mid-term dividend by the actual controller and chairman of the board of directors of the company in 2024.
SMO Clinplus: 301257 Pures research activity information on June 21, 2024.
SMO Clinplus: Articles of Association of Puris (Shanghai) Medical Technology Development Co., Ltd. (June 2024).
SMO Clinplus: 301257 Puyisi research activity information 20240605
SMO Clinplus: 301257 Pryce Research Activity Information20240517
SMO Clinplus: 301257 Prius Investor Relations Management Information 20240510
SMO Clinplus: 301257 Pryce Research Activity Information 20240430
SMO Clinplus: Huatai United Securities Co., Ltd.'s inspection opinion on the extension of some fund-raising projects of Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.
SMO Clinplus: External guarantee decision management system (April 2024)
SMO Clinplus: Huatai United Securities Co., Ltd. inspection opinions on the storage and use of funds raised by Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd. in 2023
SMO Clinplus: On the 2023 Performance Evaluation Report of Accounting Firms
SMO Clinplus: The Board's special opinion on the sole director's independence assessment
SMO Clinplus: Notice on applying for credit lines from banks
SMO Clinplus: Announcement of Supervisory Board Resolutions
No Data